Connect
MJA
MJA

The time is right to do more to reduce ACL injuries

Chris Schilling and Siddharth Rele
Med J Aust 2024; 221 (3): 147-148. || doi: 10.5694/mja2.52384
Published online: 5 August 2024

The number of anterior cruciate ligament (ACL) injuries is increasing; during 1998–2018, their incidence increased in male Australians by 5.2% per year, and by 6.2% per year in female Australians.1 While there are many reasons for the rise, increased participation in sport at all levels is postulated to be a significant contributor.1 ACL injuries increase short and long term morbidity and have significant economic costs,2,3,4 leading to the question: is prevention better, or at least more cost‐effective, than cure?

In this issue of the MJA, Ross and colleagues5 argue for a national ACL injury prevention program on the basis of their modelling of its health and economic benefits. Economic models are useful for generalisation, extrapolation, and prediction. They allow decision makers and researchers to test the broader, long term implications of a proposed intervention beyond what is feasible in a randomised or non‐randomised trial. It is encouraging to see these types of modelling exercises published in the MJA to help inform critical decision making about improving health outcomes cost‐effectively.

Ross and colleagues adopted a broad, societal perspective for their analysis, including logistic costs for implementing the program, societal costs for ACL reconstructions, the direct and indirect costs associated with knee osteoarthritis, and costs of primary and revision total knee replacement. Over 35 years, a national ACL injury prevention program was modelled to save more than $50 million, to improve quality of life by more than 400 quality‐adjusted life years, and to avert more than 4000 ACL injuries; for every dollar invested in the program, $3.51 in costs would be saved. This finding is consistent with other national public health interventions, providing a similar return on investment to a needle exchange program in Australia.6

Given the strong economic argument for the program, perhaps we should be champing at the bit to advocate its national implementation? However, models are only as good as their assumptions and data sources. The costs for implementing the program were derived from those for a similar ACL injury prevention program in New Zealand; the key assumptions regarding reach, adoption, and implementation were based on Swedish data. Consequently, questions remain about the generalisability of the model to Australia. Given earlier reports on the uptake of injury prevention advice,7 encouraging amateur sports participants to adopt and adhere to an injury prevention program may also be difficult. The assumptions for program costs and rates of program implementation, adoption, and reach were critical for the analysis by Ross and colleagues. Reassuringly, they found that the model yielded similar results when more conservative assumptions for all four sensitivity parameters were applied.5

So should we proceed with a national rollout? Ross and his colleagues highlight the need for a public health approach to help prevent ACL injuries in amateur soccer players. Their model is highly valuable for quantifying the broad costs and effects of rolling out such a program across Australia. However, its true impact remains to be determined, as are the costs of implementing it. We suggest that a pilot or initially staggered rollout of an ACL injury prevention program would be prudent, allowing all those involved to evaluate program delivery, uptake, and performance in order to determine whether the program was delivering on its potential.

Measuring the success of a primary prevention strategy is also contingent on capturing adequate data; a study is only as good as the data on which it is based. Given the health and economic burden of ACL injuries, the case for a national ACL registry is strong. It could be used to systematically monitor progress in reducing the burden of ACL injuries, and to support evaluations of ACL injury prevention programs. Evaluations nested within the data collection processes of national registries have significant economic and pragmatic advantages;8 for example, several large studies have already taken advantage of the Australian Orthopaedic Association National Joint Replacement Registry.9,10 Implementing a large scale ACL injury prevention program without processes for measuring outcomes would seem to waste its potential. The phased introduction of an ACL injury prevention program, supported by a national ACL registry for comprehensive evaluation, would facilitate best practice grounded in evidence.

 


Provenance: Commissioned; not externally peer reviewed.

  • Chris Schilling1
  • Siddharth Rele1

  • The University of Melbourne, Melbourne, VIC



Competing interests:

No relevant disclosures.

  • 1. Maniar N, Verhagen E, Bryant AL, Opar DA. Trends in Australian knee injury rates: an epidemiological analysis of 228 344 knee injuries over 20 years. Lancet Reg Health West Pac 2022; 21: 100409.
  • 2. Filbay SR, Skou ST, Bullock GS, et al. Long‐term quality of life, work limitation, physical activity, economic cost and disease burden following ACL and meniscal injury: a systematic review and meta‐analysis for the OPTIKNEE consensus. Br J Sports Med 2022; 56: 1465‐1474.
  • 3. Suter LG, Smith SR, Katz JN, et al. Projecting lifetime risk of symptomatic knee osteoarthritis and total knee replacement in individuals sustaining a complete anterior cruciate ligament tear in early adulthood. Arthritis Care Res (Hoboken) 2017; 69: 201‐208.
  • 4. Zbrojkiewicz D, Vertullo C, Grayson JE. Increasing rates of anterior cruciate ligament reconstruction in young Australians, 2000–2015. Med J Aust 2018; 208: 354‐358. https://www.mja.com.au/journal/2018/208/8/increasing‐rates‐anterior‐cruciate‐ligament‐reconstruction‐young‐australians
  • 5. Ross R, Kim J, Mc Kay M, et al. The economics of a national anterior cruciate ligament injury prevention program for amateur football players: a Markov model analysis. Med J Aust 2024; 221: 149‐155.
  • 6. Rebecca M, Elspeth A, Brendan C, et al. Return on investment of public health interventions: a systematic review. J Epidemiol Community Health 2017; 71: 827‐834.
  • 7. Minnig MC, Hawkinson L, Root HJ, et al. Barriers and facilitators to the adoption and implementation of evidence‐based injury prevention training programmes: a narrative review. BMJ Open Sport Exerc Med 2022; 8: e001374.
  • 8. Karanatsios B, Prang KH, Verbunt E, et al. Defining key design elements of registry‐based randomised controlled trials: a scoping review. Trials 2020; 21: 552.
  • 9. Peel TN, Astbury S, Cheng AC, et al; ASAP Trial Group. Trial of vancomycin and cefazolin as surgical prophylaxis in arthroplasty. N Engl J Med 2023; 389: 1488‐1498.
  • 10. CRISTAL Study Group; Sidhu VS, Kelly TL, Pratt N, et al. Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial. JAMA 2022; 328: 719‐727.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.